Intriguingly, ISL was unable to inhibit Src activity in cell-free kinase assay but it decreased the amount of Tyr416-phosphorylated Src in lung cancer cells at a concentration as low as 3 μM. The gene discussed is SRC; the disease is lung carcinoma.